Blog

Rapid COVID-19 antigen test High clinical sensitivity (> 97%) and specificity (≥ 98%) Fast and reliable test results in 15 minutes All test components are included: swabs, buffers, test cassettes, tubes and stands For specialist or trained personnel     [mkdf_inner_row_holder space_between_columns="medium" text_alignment=""][mkdf_inner_row_column column_size="6"] SAFECARE COVID-19 Antigen Rapid Test Item number: SAFE-AN-25 Anterior nasal & nasopharyngeal specimens BfArm listed and tested by the Paul Ehrlich Institute EN ISO 13485:2016 25 Tests/ Box From 3,07€ /Test (minimum purchase 50 boxes) [/mkdf_inner_row_column][mkdf_inner_row_column column_size="6"] NanoRepro COVID-19 Antigen Rapid Test Item number: B66000 BfArm listed Suitable for all three types

COVID-19 Antigen Schnelltest Hohe klinische Sensitivität (> 97%) und Spezifität (≥ 98%) Schnelle und zuverlässige Testergebnisse in 15 Minuten Alle Testkomponenten sind enthalten: Tupfer, Puffer, Testkassetten, Röhrchen und Ständer Für Fachpersonal oder geschultes Personal       [mkdf_inner_row_holder space_between_columns="medium" text_alignment=""][mkdf_inner_row_column column_size="6"] SAFECARE COVID-19 Antigen Schnelltest Artikelnummer: SAFE-AN-25 Vorderen Nasenbereich & Nasopharynx-Proben BfArm gelistet und vom Paul-Ehrlich-Institut getestet EN ISO 13485:2016 25 Tests/ Box ab 3,07€ /Test (Mindestabnahme 50 Boxen) SAFECARE_Validierungsdaten SAFECARE_Gebrauchsanweisung [/mkdf_inner_row_column][mkdf_inner_row_column column_size="6"] NanoRepro COVID-19 Antigen Schnelltest Artikelnummer: B66000 BfArm gelistet Geeignet für alle drei Abstricharten: Vorderer Nasenabstrich, tiefer Nasen- & tiefer Rachenabstrich 20 Tests/ Boxab 3,45€

The International Agency for Research on Cancer (IARC), under the World Health Organization (WHO), released its latest estimates of the global cancer burden in 2020 in CA: A Cancer Journal for Clinicians. It states that with the rapid growth and aging of the population, the number of cancer incidents and deaths worldwide is increasing rapidly, and cancer will become the leading cause of death in the 21st century. It will become the most important obstacle to increased life expectancy in countries around the world. Malignant tumors have also become one of

We will work out a workplan a project-based rate that fits your budget and fulfil your milestones before your project starts. Talk to us for a quotation. Check out our case studies to see how we can help you. Bridging the gap between biotech and A.I. Assay development for diagnostics

With technology fits we are open to collaborative R&D projects, China market entry and other opportunities. Talk to us for a potential opportunities Check out our case studies to see how we can help you. Bridging the gap between biotech and A.I. Assay development for diagnostics

Our one-stop solution takes care of the workflow and your milestones in our fully equipped class 2 lab, leaving you the resources to focus on your core technology Talk to us to know more Check out our case studies to see how we can help you. Bridging the gap between biotech and A.I. Assay development for diagnostics

We are trusted by Germany top 5 pharmaceutical company and other biotech companies, our scientist team will provide you the most reliable A.I. training data. Talk to us to know more Check out our case studies to see how we can help you. Bridging the gap between A.I. and Biotech Assay development for diagnostics

The detection under the light microscope has been until now the gold standard for malaria acute diagnosis because it fulfils most of important diagnostic criteria [1]: Provided that a trained and skilled lab worker is performing the method and interpretation, Plasmodium parasites can be detected, identified and specified by morphological criteria. Also, differentiation of the life cycle stages of the parasites, quantification, and monitoring the effectiveness of malaria treatment is possible. The method is easy to perform and relatively low in cost. For microscopic examination, a specimen of the patient’s blood is smeared

In the last years, the use of Rapid Diagnostic Tests (RDTs) has increased a lot for acute diagnosis, especially in sub-Saharan Africa. There, 75 % of malaria tests have been carried out with RDTs in 2017 [1]. The RDTs are based on the reaction with specific parasitic antigens. There are several RDTs on the market which vary according to specificity. For the test, blood from a finger prick is taken and introduced to the RDT card. The result is shown in form of bands on the test card window within a

Diagnosis of Malaria parasites has got high relevance in many parts of the world. The significant numbers of malaria infections and high death rates throughout the years make malaria the most dangerous parasitic infection worldwide. For example, these global referring numbers are given by the WHO in its world malaria report 2019 [1]:   in 2018 there were 228 million malaria cases. compared to that: in 2010 there were 251 million malaria cases.   In the same years death rates were remarkable: in 2018 there were 405,000 deaths from malaria. And earlier: in 2010 there were 585,000 deaths from malaria.   We can

    OneWorld Diagnostics has always aimed to bridge the medical development in between the World and Germany. We wish to fight against the current COVID-19 outbreak with you, and therefore are proud to give you a special offer on respirators. The respirators are imported by our partner, an established german MedTech company since 25 years ago. Against COVID-19 - 3 types of products with different filtration efficiencies that fits your needs: from daily use to maximum protection. High quality - CE – approved Competitive pricing - Contact us for quotations In order to contribute our part to control the COVID-19 outbreak, clinics with higher risk of infection or higher medical need would be the top

Tuberculosis has remained a global health burden, causing morbidity and mortality in millions of people worldwide. The rapid detection of infection is critical in the management and control of disease spread